Editor’s Letter
What to look forward to in GaBI Journal, 2018, Issue 2
The second issue of the 2018 GaBI Journal volume is being published at a time of increasing uncertainty concerning trade, tariffs, regulations as well as international and even inter-ally co-operation.… Read More »
Editor’s introduction to the initial issue of the seventh volume of GaBI Journal
There are many frustrating differences between reality and what is possible in every aspect of life, including politics, economics, science and health. This issue begins with a Commentary by Adjunct… Read More »
Fourth and final issue of GaBI Journal’s sixth volume
Change is inevitable but often resisted, including or even especially in medicine. Hand washing is still neglected 170 years after Semmelweis’ work, misuse of antibiotics persists 72 years after Fleming… Read More »
Latest features in GaBI Journal, 2017, Issue 3
It is clear that greater use of generics and biosimilars could greatly decrease healthcare costs and thereby increase availability of important medicines. It is equally clear that these potential savings… Read More »
What to look forward to in GaBI Journal, 2017, Issue 2
The use both generics and biosimilars offers the potential to increase availability of medicines through decreases in cost that should occur when an expensive product (drug) loses patent protection and… Read More »
Editor’s introduction to the initial issue of the sixth volume of GaBI Journal
This first issue of 2017 includes a range of manuscripts of interest to readers. A Letter to the Editor from Professor Mohamed Izham Mohamed Ibrahim and Nada Moustafa Abdel Rida… Read More »
Fourth and final issue of GaBI Journal’s fifth volume
This fourth and final GaBI Journal issue of 2016 begins with the paper by Adjunct Professor Pekka Kurki about ‘applying ancient principles in a modern society’ in which he discusses… Read More »
Latest features in GaBI Journal, 2016, Issue 3
The informed, appropriate use of follow-on pharmacological agents can provide significant cost savings for patients and payers. These savings can then be used by governments and patients to increase access… Read More »
What to look forward to in GaBI Journal, 2016, Issue 2
This second issue of 2016 includes manuscripts that cover a number of important issues of interest to GaBI Journal including methods used to assess bioequivalence and decide on interchangeability, patient and… Read More »
Editor’s introduction to the initial issue of the fifth volume of GaBI Journal
This issue begins with a Letter to the Editor by Professor Fabio V Teixeira from the Brazilian Inflammatory Bowel Disease (IBD) Society that deals basically with the issue of extrapolation… Read More »